PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534415
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534415
Japan HealthTech Market Size Expands at Significant CAGR of 6.16% to Surpass Value of USD 695.12 Million by 2030
Japan HealthTech Market is flourishing because of an increasing demand for medical and nursing care in urban areas and labor shortage in the healthcare care sector.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Japan HealthTech Market size at USD 346.48 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Japan HealthTech Market size to expand at a CAGR of 6.16% reaching a value of USD 695.12 million by 2030. The country's aging population and the increasing introduction of healthcare technology, such as wearables and mHealth applications, are key drivers of the Japan Healthtech Market. Over the forecast period, Japan Healthtech Market is also expected to be driven by a severe labor shortage in the nursing and medical care sectors.
Opportunity: High Prevalence of diabetes and other chronic diseases
Japan HealthTech Market, based on application, is segmented into cardiology, diabetes, neurology, sleep apnea, oncology, and others. The diabetic segment holds the largest share in the market owing to the high prevalence of the chronic disease in Japan. According to the National Institutes of Health, currently, type 2 diabetes, or impaired glucose tolerance, affects around 13.5% of the population in Japan. Healthtech facilitates better management of diabetes through continuous glucose monitoring (CGM) system, smart insulin pens, real-time health data, qualitative hypoglycemia alarms, and others, which allows healthcare providers to make informed decisions.
Impact of Escalating Geopolitical Tensions on Japan HealthTech Market
The escalating geopolitical tensions may disrupt the Japan Healthtech market. Japan and Israel have close ties in the healthtech sector owing to the technological assets offered by the latter. However, divestment campaigns against Israel are being launched, which might impede potential collaboration between the two nations. Lack of manpower and funding is another factor impeding Israel's technology sector operations, which might have a direct impact on Japan Healthtech Market and may restrict its expansion.
Japan HealthTech Market
Segmental Coverage
Japan HealthTech Market - By End User
Based on end user, Japan HealthTech Market is segmented into healthcare providers, healthcare payers, healthcare consumers, pharmaceutical companies, and others. The healthcare consumers segment dominates Japan Healthtech Market. The growth of the segment is mainly attributed to the increasing launches of healthtech devices and the rising availability and accessibility of patient-care services. Healthtech offers many conveniences to patients in terms of healthcare accessibility, such as remote monitoring and access to health information. Patients can track and share their vitality with their healthcare professionals remotely, which acts as a major driving force for market growth.
Competitive Landscape
Major players operating in Japan HealthTech Market include Allm Inc., M3, Inc., Omron, Whill, FiNC, CureApp, AI Medical Service, Awarefy, and iCARE. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and Japan HealthTech Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Japan HealthTech Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.